Background: Researches have revealed that the endothelial nitric oxide synthase (eNOS) gene G894T polymorphism is associated with the risk of Myocardial infarction (MI), but the results remain conflicting.
Introduction
Myocardial infarction (MI) is a complex syndrome determined by multiple predisposing genetic and environmental factors. Previous studies have investigated the association of genetic variants in DNA repair pathways, lipid-related pathways, fibrinolytic system, renin angiotensin aldosterone system and nitric oxide synthase with MI risk [1, 2, 3, 4, 5] .
There are several forms of nitric oxide synthase such as neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS). The vascular nitric oxide (NO), mainly produced by eNOS, is a critical molecule in regulating the vascular system, including the inhibition of the platelet aggregation and adhesion and reduction of vascular smooth muscle cell proliferation [6] . Furthermore, overproduction of NO can inhibit DNA repair and cause DNA damage [7] , which plays an important role in the occurrence of MI [3] . NO regulation may result from the functional eNOS genetic polymorphisms. The eNOS gene is mapped on human chromosome 7q35-36 and contains 26 exons and 25 introns. The eNOS G894T polymorphism, a coding region variant, results in a Glu298Asp substitution and decreases the NO levels [8] .
To date, studies on the association of eNOS G894T polymorphism with MI clinical phenotype have been extensively explored. However, the results still remain inconclusive and conflicting. Some studies found that the allele T of eNOS G894T polymorphism was the risk factor for MI, but others had the opposite results. Therefore, in the current study, a meta-analysis from 34 individual studies with a total of 21068 subjects including 8229 cases and 12839 controls was performed to get a more precise estimation of the association between eNOS G894T polymorphism and MI.
Materials and Methods

Publication Search and Inclusion Criteria
We searched the electronic databases PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBM) using the following search terms: (myocardial infarction or myocardial infarct) and (endo-thelial nitric oxide synthase) and (polymorphism or mutation or variant), without restriction on language. The included articles were published before September 2013. All eligible studies were retrieved, and their references were examined manually for other potentially relevant studies.
The inclusion criteria were as follows: a) case-control design. b) the association of eNOS G894T polymorphism with MI should be evaluated. c) the genotype data was available in the cases and controls. d) the control subjects must be in agreement with the Hardy-Weinberg equilibrium (HWE).
Data Extraction
All data were independently collected from the included studies according to a standardized protocol by two investigators. The discrepancies during data extraction were resolved by consensus. The same data in different studies were used only once. The following information was extracted: first author's name, publication year, original country, ethnicity, sample size, and number of genotype in cases and controls. 
Statistical Analysis
The association between eNOS G894T polymorphism and MI was assessed using crude odds ratio (OR) with 95% confidence interval (CI). The pooled ORs were determined for homozygous model (TT versus GG), heterozygous model (GT versus GG), recessive model (TT versus GT/GG), dominant model (GT/TT versus GG). The Z test was used to assess the pooled OR with the significance set at P,0.05. HWE was assessed using the Chisquare test in control groups. The presence of between-study heterogeneity was evaluated by using the I 2 statistic test, which does not inherently depend on the number of studies in the metaanalysis and is preferable to the test of heterogeneity [9] . The value of I 2 ranged from 0-100%. If obvious heterogeneity was observed among the studies (I 2 .50%), the random-effects model (the DerSimonian and Laird method) was used to calculate the pooled OR and 95% CI [10] . Otherwise, the fixed-effects model (the Mantel-Haenszel method) was adopted for the meta-analysis [11] . Subgroup analyses according to the ethnicity and the total sample size were also performed to evaluate the association. When stratified by total sample size, we defined the large group if the sample size was more than 1000 and the small group if the sample size was less than 400, otherwise was the medium group. Metaregression was performed to explore the sources of between-study heterogeneity. The study ethnicity, total sample size, control sample size, MI sample size, ratio of MI sample size to control sample size, publication year were regarded as the potential confounding factors. Sensitivity analyses were conducted to evaluate the effect of individual study on pooled results and assess the stability of results. The potential publication bias was detected with Begg's funnel plot [12] , and the funnel plot asymmetry was assessed by Egger's linear regression test [13] . All statistical analyses were performed using the STATA 12.0 software (StataCorp, College Station, TX, USA).
Results
Characteristics of Eligible Studies
Our meta-analysis was performed according to guidelines of the ''Preferred Reporting Items for Systematic reviews and MetaAnalyses'' (PRISMA) statement (Supplement S1) [14] . A total of 417 relevant papers were yielded by the literature search, among which 34 studies met the inclusion criteria, including 8229 MI cases and 12839 controls. As is showed in the flow diagram (Supplement S2), 372 papers were excluded owing to the obvious irrelevance. We reviewed the full texts of the remaining 45 articles. Among them, 2 were reviews, 4 were duplicated publications, 3 had no controls, 4 had insufficient data for calculation of OR and 95% CI and 1 was deviated from the HWE. At last, a total of 34 studies for the association between eNOS G894T polymorphism and MI risk were obtained in the final meta-analysis. Data collected from the included studies were summarized in the Table 1 . Those included studies in Japan, Australia, France, Northern Ireland, United Kingdom, Germany, Turkey, Greece, Korea, Brazil, Sweden, Poland, Hungary, Mexico, India, Egypt, Netherlands and China.
Results of Meta-analysis
A significant association between eNOS G894T polymorphism and MI was found under a homozygous genetic model (OR = 1.41, 95% CI = 1.08-1.84; P = 0.012), a heterozygous genetic model (OR = 1.12, 95% CI = 1.00-1.25; P = 0.054), a recessive genetic model (OR = 1.35, 95% CI = 1.06-1.70; P = 0.014), a dominant genetic model (OR = 1.18, 95% CI = 1.04-1.34; P = 0.009) ( Table 2) .
Subgroup analysis stratified by ethnicity also suggested a significant association between eNOS G894T polymorphism and MI in the Asian subgroup under a homozygous genetic model (OR = 3.44, 95% CI = 2.15-5.49; P = 0.000), a heterozygous genetic model (OR = 1.26, 95% CI = 1.02-1.57; P = 0.032), a recessive genetic model (OR = 3.41, 95% CI = 2.14-5.43; P = 0.000), and a dominant genetic model (OR = 1.40, 95% CI = 1.13-1.74; P = 0.002). In contrast, no significant association was observed in the non-Asian subgroup under any of the genetic models (P.0.05) ( Table 2 ; Figures 1 and 2 ;Supplements S3 and S4). Stratified analyses by the total sample size also suggested that eNOS G894T polymorphism increased the MI risk both in large sample size studies and small sample size studies (Table 2 ; Figures 3  and 4) .
Sources of Heterogeneity
Under homozygous and recessive genetic models, metaregression revealed that ethnicity was the sources of betweenstudy heterogeneity (P = 0.007, P = 0.004 respectively), which was consistent with subgroup analyses results in homozygous and recessive genetic models (Table 2 ; Figures 1 and 2) . Moreover, under the dominant genetic model, meta-regression showed that ,50%, it was for fixed effect model, otherwise it was for random effect model. Small study: studies with less than 400 participants; Medium study: studies with more than 400 and less than 1000 participants; Large study: studies with more than 1000 participants. doi:10.1371/journal.pone.0087196.t002 ethnicity might be the sources of between-study heterogeneity (P = 0.058), which was also consistent with subgroup analyses results in the dominant genetic model (Table 2 ). In addition, subgroup analyses revealed that the heterogeneity was significantly reduced in the small sample size group and large sample size group in all genetic models, suggesting that the total sample size was the source of heterogeneity (Table 2 ; Figures 3 and 4) .
Sensitivity Analysis
A single study was excluded each time to evaluate the effect of individual study on the combined ORs and 95% CIs. The omission of any single study did not make significant difference in the pooled effects of homozygous, heterozygous, recessive and dominant genetic models, suggesting a high stability of our metaanalysis results (data not shown). 
Publication Bias
Publication bias of the selected articles was assessed by the Begg's funnel plot and Egger's test. The shape of the funnel plot did not show obvious publication bias ( Figure 5) . Similarly, no evidence of publication bias was observed by Egger's test (P = 0.075 for homozygous genetic model; P = 0.299 for heterozygous genetic model; P = 0.118 for dominant genetic model; P = 0.055 for recessive genetic model).
Discussion
In the current meta-analysis with 8229 cases and 12839 controls, we found that there were significant associations between eNOS G894T polymorphism and MI: OR = 1.41 for the homozygous genetic model, OR = 1.12 for the heterozygous genetic model, OR = 1.35 for the recessive genetic model, and OR = 1.18 for the dominant genetic model. Further stratified analysis revealed that the eNOS G894T polymorphism was significantly A number of association studies have investigated the association between the eNOS G894T polymorphism and the risk of coronary artery disease (CAD), MI, coronary spasms and hypertension [5, 48, 49] . Mechanism study has also suggested the mutation was functional in the production of NO [8] . Human study showed that blood pressure decrease in the eNOS 894TT carriers was greater than the other genotypes carriers after the exercise training [50] . Therefore, subjects carrying the eNOS 894TT genotype may have low NO in vivo and are more susceptible to endothelial dysfunction, which might increase the risk of MI. The present meta-analysis results of homozygous and recessive genetic models can account for the above hypothesis. Nevertheless, the number of TT genotype is relatively small in Asia populations and the 95%CI line of the pooled OR for Asia populations is longer than that for non-Asia population studies in Figure 1 and 2. So the results of homozygous and recessive genetic models in Asia populations need to be further confirmed in future.
Conflicting results have been reported in investigating the association of the eNOS G894T polymorphism with MI. To our knowledge, our meta-analysis represents the first one focusing on the association between eNOS G894T polymorphism and the risk of MI. In 2004, Casas et al [51] . performed a meta-analysis to evaluate the association between eNOS G894T polymorphism and ischemic heart disease (IHD) including MI and CAD. They found that individuals homozygous for the eNOS 894T allele were at moderately increased risk of IHD. In 2012, the meta-analysis results of Zhang indicated that eNOS G894T polymorphism was associated with CAD risk among Asia population [5] . However, the above two meta-analysis did not evaluate the association between eNOS G894T polymorphism and MI. Our meta-analysis provided a precise result regarding the association of eNOS G894T polymorphism with MI risk.
Between-study heterogeneity is common and should be explored in the meta-analysis. In the current study, significant heterogeneity was found in the association of eNOS G894T polymorphism with MI risk. Therefore, meta-regression and subgroup analyses were performed to explore the sources of between-study heterogeneity. The results indicated that ethnicity was the source of heterogeneity in the homozygous and recessive genetic models and total sample size was the source of heterogeneity in all genetic models. Sensitivity analysis revealed that the omission of any single study did not have significant impact on the overall meta-analysis estimate. Furthermore, in the meta-analysis, funnel plot did not reflect considerable asymmetry and Egger's test also indicated no obvious publication bias. All these made the meta-analysis results reliable to some extent.
There are some limitations in this meta-analysis. First, our meta-analysis was based primarily on the unadjusted ORs with 95% CIs and the potential confounding factors were not available. Second, gene-gene and gene-environment interactions may play important roles in the function of eNOS G894T polymorphism, but the effect was not addressed in our meta-analysis.
In conclusion, this meta-analysis demonstrated that the eNOS G894T polymorphism was associated with increased risk of MI. Further stratification by ethnicity indicated the association between the polymorphism and MI was restricted in the Asians.
However, large-scale studies well designed for the gene-gene and gene-environment interactions information are needed to be conducted to elucidate the associations in future. 
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